<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xmlns:xhtml="http://www.w3.org/1999/xhtml">
  <url>
    <loc>https://www.lennham.com/news</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2022-05-31</lastmod>
  </url>
  <url>
    <loc>https://www.lennham.com/news/lennham-pharmaceuticals-announces-issuance-of-us-patent-covering-deuterated-psilocybin-products</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2021-05-17</lastmod>
  </url>
  <url>
    <loc>https://www.lennham.com/news/lennham-pharmaceuticals-announces-topline-results-from-pharmacokinetic-study-of-d9-caffeine-versus-caffeine</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2021-06-18</lastmod>
  </url>
  <url>
    <loc>https://www.lennham.com/news/lennham-presents-topline-data-from-human-pk-study-of-d9-caffeine-vs-caffeine-at-issn-2021</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2021-06-18</lastmod>
  </url>
  <url>
    <loc>https://www.lennham.com/news/lennham-pharmaceuticals-expands-leading-psilocybin-patent-portfolio-with-addition-of-new-patent-family</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2021-09-10</lastmod>
  </url>
  <url>
    <loc>https://www.lennham.com/news/lennham-pharmaceuticals-announces-discovery-of-next-generation-testosterone-candidate</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2021-12-01</lastmod>
  </url>
  <url>
    <loc>https://www.lennham.com/news/lennham-publishes-manuscript-detailing-the-nonclinical-pk-and-safety-evaluation-of-d9-caffeine-in-food-and-chemical-toxicology</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2022-01-28</lastmod>
  </url>
  <url>
    <loc>https://www.lennham.com/news/lennham-pharmaceuticals-announces-issuance-of-us-patent-covering-methods-of-administering-psilocybin-and-psilocin</loc>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
    <lastmod>2022-05-31</lastmod>
  </url>
  <url>
    <loc>https://www.lennham.com/about</loc>
    <changefreq>daily</changefreq>
    <priority>1.0</priority>
    <lastmod>2021-04-01</lastmod>
  </url>
  <url>
    <loc>https://www.lennham.com/dcaffeine</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2022-01-28</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/605de5d23e53c24d331e0ee6/24faa766-7932-4ba6-8770-c67060fe7d19/d9+human+pk+figure+1.png</image:loc>
      <image:title>d-Caffeine</image:title>
      <image:caption>Arithmetic mean plasma concentration over 48 hours following single dose administration of 50 mg caffeine and molar equivalent of d9-caffeine</image:caption>
    </image:image>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/605de5d23e53c24d331e0ee6/8bd8e596-eb42-45a3-adb8-56308ccb93b5/d9+table.png</image:loc>
      <image:title>d-Caffeine</image:title>
      <image:caption>Pharmacokinetic parameters and relative disposition of d9-caffeine, caffeine, and their respective major metabolites following administration of 50 mg caffeine or a molar equivalent of d9-caffeine</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.lennham.com/contact</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-04-01</lastmod>
  </url>
  <url>
    <loc>https://www.lennham.com/dpsilocybin</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-09-01</lastmod>
  </url>
  <url>
    <loc>https://www.lennham.com/science</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-04-01</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/605de5d23e53c24d331e0ee6/1617046203277-65URHGIF3NEPW2JWGSCL/HvsD.png</image:loc>
      <image:title>Science</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://www.lennham.com/dtestosterone</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2022-02-28</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/605de5d23e53c24d331e0ee6/edccc8ce-3765-4311-9d41-2396b5a84ec4/d3t+data.png</image:loc>
      <image:title>d-Testosterone - Make it stand out</image:title>
      <image:caption>Whatever it is, the way you tell your story online can make all the difference.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.lennham.com/pipeline</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2022-01-28</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/605de5d23e53c24d331e0ee6/a60f90f3-12a7-4b73-8b29-97dc935c6b8a/jan+2022+pipeline_lnp.png</image:loc>
      <image:title>Pipeline</image:title>
      <image:caption>* IP includes combination with other active ingredients, including unlabeled caffeine</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.lennham.com/issn</loc>
    <changefreq>daily</changefreq>
    <priority>0.75</priority>
    <lastmod>2021-06-18</lastmod>
    <image:image>
      <image:loc>https://images.squarespace-cdn.com/content/v1/605de5d23e53c24d331e0ee6/1624028526221-RA8T7SA73GZD9Z2T0390/D9+ISSN+Poster+June+2021.jpg</image:loc>
      <image:title>ISSN Poster</image:title>
    </image:image>
  </url>
</urlset>

